These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 31255931)

  • 1. Posttreatment With LYRM03 Protects Rats From Acute Lung Inflammation Induced by Lipopolysaccharide via Suppressing the NF-κB/MyD88/TLR4 Axis.
    Jiang Q; Wang S; Shi Y
    J Surg Res; 2019 Nov; 243():316-324. PubMed ID: 31255931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals.
    Wang B; Wang J; Lu D; Qi N; Liu Q
    J Invest Surg; 2021 Mar; 34(3):284-296. PubMed ID: 31274341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway.
    He HQ; Wu YX; Nie YJ; Wang J; Ge M; Qian F
    Acta Pharmacol Sin; 2017 Mar; 38(3):342-350. PubMed ID: 28112185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
    Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
    Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penehyclidine Hydrochloride Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Ameliorating Apoptosis and Endoplasmic Reticulum Stress.
    Ye S; Yang X; Wang Q; Chen Q; Ma Y
    J Surg Res; 2020 Jan; 245():344-353. PubMed ID: 31425874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-κB pathway in rats.
    Zhou J; Deng Y; Li F; Yin C; Shi J; Gong Q
    Biomed Pharmacother; 2019 Mar; 111():315-324. PubMed ID: 30590319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of the suppressed NF-κB/TLR4 signaling pathway on oxidative stress of lung tissue in rat with acute lung injury.
    Zhang ZM; Wang YC; Chen L; Li Z
    Kaohsiung J Med Sci; 2019 May; 35(5):265-276. PubMed ID: 31001923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbelliferone Alleviates Lipopolysaccharide-Induced Inflammatory Responses in Acute Lung Injury by Down-Regulating TLR4/MyD88/NF-κB Signaling.
    Wang D; Wang X; Tong W; Cui Y; Li X; Sun H
    Inflammation; 2019 Apr; 42(2):440-448. PubMed ID: 30645708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
    Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
    Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats.
    Wu Y; Huang D; Wang X; Pei C; Xiao W; Wang F; Wang Z
    Int Immunopharmacol; 2021 Jul; 96():107621. PubMed ID: 33872850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hesperetin ameliorates lipopolysaccharide-induced acute lung injury in mice through regulating the TLR4-MyD88-NF-κB signaling pathway.
    Wang N; Geng C; Sun H; Wang X; Li F; Liu X
    Arch Pharm Res; 2019 Dec; 42(12):1063-1070. PubMed ID: 31802426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sevoflurane inhibits nuclear factor-κB activation in lipopolysaccharide-induced acute inflammatory lung injury via toll-like receptor 4 signaling.
    Sun XJ; Li XQ; Wang XL; Tan WF; Wang JK
    PLoS One; 2015; 10(4):e0122752. PubMed ID: 25875290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphA2 antagonism alleviates LPS-induced acute lung injury via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways.
    Feng G; Sun B; Liu HX; Liu QH; Zhao L; Wang TL
    Int Immunopharmacol; 2019 Jul; 72():176-185. PubMed ID: 30986645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis-induced acute lung injury in young rats is relieved by calycosin through inactivating the HMGB1/MyD88/NF-κB pathway and NLRP3 inflammasome.
    Chen G; Hou Y; Li X; Pan R; Zhao D
    Int Immunopharmacol; 2021 Jul; 96():107623. PubMed ID: 33857805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats.
    Li G; Li J; Zhou Q; Song X; Liang H; Huang L
    Tohoku J Exp Med; 2010 Sep; 222(1):7-13. PubMed ID: 20805679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway.
    Zhang Z; Chen N; Liu JB; Wu JB; Zhang J; Zhang Y; Jiang X
    Mol Med Rep; 2014 Jul; 10(1):101-6. PubMed ID: 24818579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.